Trials / Recruiting
RecruitingNCT01890486
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
The Prospective Collection, Storage and Reporting of Data on Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Detailed description
To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach. To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.
Conditions
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
- Multiple Myeloma
- Germ Cell Neoplasms
- Myelodysplastic Syndromes
- Chronic Lymphocytic Leukemia
- Immunodeficiency Diseases
Timeline
- Start date
- 2001-05-21
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2013-07-01
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01890486. Inclusion in this directory is not an endorsement.